Skip to content

Evaluation of Videolaryngoscopes in Difficult Airway (SWIVITII)

Phase 2 Study of Evaluation of Videolaryngoscopes in Difficult Airway (SWIVITII)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02088801
Acronym
SWIVITII
Enrollment
480
Registered
2014-03-17
Start date
2014-02-28
Completion date
2015-06-30
Last updated
2015-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Difficult Intubation

Keywords

Intubation; Difficult

Brief summary

In this second phase of the multicenter study the investigators are going to evaluate the use of three different videolaryngoscopes in patients undergoing elective surgery requiring general anesthesia with intubation. The investigators are hypothesizing that these three videolaryngoscopes will succeed for intubation at first attempt in at least 90% of all cases using a difficult airway simulation with extrication collars. As the gold standard, a standard Macintosh blade is being used for comparison. The study consists of 4 arms. Each arm includes 120 patients, sums up to a total of 480 patients.

Interventions

DEVICEAirtraq, blade without channel for tracheal tube intubation

Intubation

DEVICEKingVision , blade without channel for tracheal tube intubation
DEVICEA.P. Advance, blade without channel for tracheal tube intubation
DEVICEMacintosh

Sponsors

Insel Gruppe AG, University Hospital Bern
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* elective surgery with general anesthesia requiring intubation * \>18 years old * ASA I-III

Exclusion criteria

* known or presumed difficult airway * risk of pulmonary aspiration * refusing to participate

Design outcomes

Primary

MeasureTime frame
first attempt intubation success rateintraoperative

Secondary

MeasureTime frameDescription
side effects1h and 1day after intubationsore throat, bleeding, dental injuries

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026